Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant To Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology

(MENAFN- PR Newswire) More
than
$274,000
in
NSF
funding to
develop
breakthrough
aneurysm
sac management
technology

COSTA MESA,
Calif., July 15, 2024 /PRNewswire/ -- Life Seal Vascular Inc.
( ), a pioneering company dedicated to revolutionizing
endovascular treatment, is thrilled to announce that it has been awarded the highly competitive National Science Foundation (NSF)
Small Business
Innovation
Research (SBIR) grant. This
funding will
accelerate the development of Life Seal
Vascular's
cutting-edge technology to
improve patient outcomes and advance the field of endovascular aortic repair (EVAR).

"We are honored to
receive this
prestigious
SBIR grant from the NSF. This
funding is
a testament
to
the
innovative
potential
of
our
technology
and
our
commitment
to
advancing EVAR care," said Bob Mitchell, Executive Chairman of the Board at Life Seal Vascular Inc. "With this support, we are well-positioned to advance the development of our breakthrough aneurysm sealing solutions and make a significant impact on the lives of EVAR patients worldwide."

The
NSF
SBIR
grant
will
enable
Life
Seal
Vascular to
further
develop its
proprietary aneurysmal sac sealing technology. Designed as an adjunctive therapy to native
endografts, Life Seal Vascular's groundbreaking approach seals the entire aneurysmal sac potentially eliminating endoleaks, reducing reintervention rates and improving clinical outcomes for EVAR patients.

Dr. Michel Reijnen, a renowned vascular surgeon, commented on the significance of Life Seal Vascular's technology, stating, "The advancements being made by Life Seal Vascular are
truly remarkable.
Their innovative
solutions
have
the
potential
to
revolutionize
EVAR, offering patients
safer and more effective treatment options. I
am excited to
see the
positive
impact
this
technology
will
have
on
the
field
and
on
patient
care."

The
NSF
SBIR program is a highly competitive initiative that supports scientific excellence and technological innovation through the investment of federal research funds. Life Seal Vascular's selection for this grant underscores the company's dedication to advancing medical technology and its potential to deliver transformative healthcare solutions.

This grant
is
supported by the
U.S.
National
Science Foundation
under award
number 2407378.

About Life Seal Vascular, Inc.
Life Seal Vascular Inc. specializes in innovative sealing technologies for endovascular repair of aortic aneurysms. Their proprietary solutions has the potential to eliminate
endoleaks, the
main
cause
of
reinterventions
in
Endovascular Aneurysm Repair (EVAR). By completely sealing the aneurysm, Life Seal Vascular's devices ensure predictable deployment
and
do
not
interfere
with
imaging,
thereby enhancing
the
effectiveness
and safety of endovascular repair procedures.

For
more
information
about
Life
Seal
Vascular
Inc.
and
its
groundbreaking
technology, please visit [ ]( ).

About U.S. National Science Foundation Small Business Program
America's Seed Fund powered by the
U.S. National Science Foundation Small Business programs focuses on transforming scientific and engineering discoveries into products and services with commercial and societal impact. The deep technologies that are funded show promise, but their success hasn't yet been validated. And, each year, the NSF
awards
$200+ million
in
research and
development
(R&D)
funding
to
about 400
startups
across the United States. America's Seed Fund is a program within the National Science Foundation and housed within the Directorate for Technology, Innovation and Partnerships.

Media Contact:
Bob Mitchell
Executive
Chairman
of
the
Board

Life Seal Vascular Inc.
Hannah Friend
602-618-3377
[email protected]

SOURCE Life Seal Vascular, Inc.

MENAFN15072024003732001241ID1108440789